-
Subject Areas on Research
-
A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis.
-
A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
-
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
-
A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.
-
A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis.
-
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.
-
A computer based index for the prediction of operative survival in patients with cirrhosis and portal hypertension.
-
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
-
A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection.
-
A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.
-
A man with type III glycogenosis associated with cirrhosis and portal hypertension.
-
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.
-
A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
-
ACR Appropriateness Criteria® Chronic Liver Disease.
-
Aberrant venous drainage to the liver: imaging implications.
-
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.
-
Acetylcholine promotes the proliferation and collagen gene expression of myofibroblastic hepatic stellate cells.
-
Actions of thrombin in the interstitium.
-
Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells.
-
Activities of the hepatic enzymes of vitamin B6 metabolism for patients with cirrhosis.
-
Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.
-
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.
-
After goodbye? Dead hepatocytes as a biomarker for fibrosis and steatohepatitis.
-
Aging of the Liver: What This Means for Patients with HIV.
-
Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
-
Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic.
-
Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.
-
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
-
Alpha-1-antitrypsin globules in hepatocytes of elderly persons with liver disease.
-
Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension.
-
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
-
An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.
-
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
-
An index based on deep learning-measured spleen volume on CT for the assessment of high-risk varix in B-viral compensated cirrhosis.
-
Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma.
-
Analyzing the Impact of Increasing Mechanical Index and Energy Deposition on Shear Wave Speed Reconstruction in Human Liver.
-
Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injury.
-
Antifibrotic therapies: will we ever get there?
-
Antiplatelet Medications Are Associated With Bleeding and Decompensation Events Among Patients With Cirrhosis.
-
Apoptosis and cytokines in non-alcoholic steatohepatitis.
-
Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.
-
Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis.
-
Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
-
Association between puberty and features of nonalcoholic fatty liver disease.
-
Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
-
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
-
Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.
-
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
-
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
-
Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults.
-
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.
-
Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
-
Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?
-
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.
-
CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis.
-
Candida albicans cholecystitis.
-
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
-
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study.
-
Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.
-
Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
-
Characterization of a canine model of glycogen storage disease type IIIa.
-
Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
-
Circular RNA RSF1 promotes inflammatory and fibrotic phenotypes of irradiated hepatic stellate cell by modulating miR-146a-5p.
-
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care.
-
Cirrhosis of the liver in long-term marrow transplant survivors.
-
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
-
Clinical Progress Note: Intravenous Human Albumin in Patients With Cirrhosis.
-
Clinical and imaging predictors of the natural course of bland portal vein thrombus in cirrhotic patients.
-
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.
-
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
-
Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.
-
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
-
Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease.
-
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.
-
Comparison of pulsed Doppler sonography and angiography in patients with portal hypertension.
-
Comparison of the grading of esophageal varices by transnasal endoluminal ultrasound and esophagogastroduodenoscopy.
-
Computed tomography findings in liver fibrosis and cirrhosis.
-
Contemporary management of pain in cirrhosis: Toward precision therapy for pain.
-
Correction of glycogen storage disease type III with rapamycin in a canine model.
-
Correction: Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease.
-
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
-
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
-
Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis.
-
Current management of sinusoidal portal hypertension.
-
Current status of fibrosis markers.
-
Cytokines and the pathogenesis of non-alcoholic steatohepatitis.
-
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
-
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.
-
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
-
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies.
-
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum.
-
Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis.
-
Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging.
-
Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT.
-
Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study.
-
Developmental Morphogens & Recovery from Alcoholic Liver Disease.
-
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.
-
Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
-
Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?
-
Diagnosis of liver fibrosis: present and future.
-
Diagnosis of nonalcoholic fatty liver disease.
-
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.
-
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
-
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.
-
Differential diagnosis of ascites.
-
Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
-
Disorders of iron metabolism.
-
Does this patient with liver disease have cirrhosis?
-
Donor derived HSV hepatitis in a kidney transplant recipient leading to liver fibrosis and portal hypertension.
-
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin.
-
Dual-Energy Multidetector Computed Tomography With Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced Phase?
-
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.
-
Early use of TIPS for cirrhosis and variceal bleeding.
-
Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice?
-
Editorial: platelet transfusions in cirrhosis-do the risks outweigh the unclear benefits?
-
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.
-
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
-
Effect of bilirubin UDP glucuronosyltransferase 1 gene TATA box genotypes on serum bilirubin concentrations in chronic liver injuries.
-
Effect of obstructive sleep apnea on the sleep architecture in cirrhosis.
-
Effect of the nitric oxide donor V-PYRRO/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice.
-
Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
-
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH.
-
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
-
Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities.
-
Elaboration of tubules with active hedgehog drives parenchymal fibrogenesis in gestational alloimmune liver disease.
-
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement.
-
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement.
-
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
-
Emergency portacaval shunts: is Orloff correct?
-
Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.
-
Epithelial-mesenchymal transitions and hepatocarcinogenesis.
-
Epithelial-to-mesenchymal transitions in the liver.
-
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
-
Evidence for and against epithelial-to-mesenchymal transition in the liver.
-
Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
-
Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.
-
Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degeneration.
-
Factors influencing the participation of gastroenterologists and hepatologists in clinical research.
-
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
-
Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers.
-
Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B.
-
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.
-
Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.
-
Fine needle aspiration biopsy of the liver.
-
Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
-
Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis.
-
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study.
-
Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis.
-
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
-
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
-
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.
-
Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
-
Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice.
-
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
-
Getting a "Grip" on Sarcopenia for the Liver Transplant Candidate: Time to Focus on Muscle Function.
-
Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.
-
Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.
-
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
-
Glycogen storage disease type IX: novel PHKA2 missense mutation and cirrhosis.
-
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
-
HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.
-
Hedgehog Signaling is Associated with Liver Response to Fractionated Irradiation in Mice.
-
Hedgehog controls hepatic stellate cell fate by regulating metabolism.
-
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease.
-
Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
-
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
-
Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis.
-
Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile.
-
Hepatic arterial resistive indices: correlation with the severity of cirrhosis.
-
Hepatic complications of obesity.
-
Hepatic complications of obesity.
-
Hepatic fibrogenesis requires sympathetic neurotransmitters.
-
Hepatic fibrosis associated with aging in four stocks of mice.
-
Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.
-
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.
-
Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.
-
Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury.
-
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
-
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
-
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.
-
Hepatocellular Carcinoma Surveillance.
-
Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?
-
Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.
-
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
-
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.
-
Hepatocellular carcinoma: clinical and angiographic findings and predictability for surgical resection.
-
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
-
High-risk third trimester pregnancy with decompensated cirrhosis safely delivered following emergent preoperative interventional radiology for mitigation of variceal bleeding.
-
Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.
-
Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.
-
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
-
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
-
Identification and Management of Abdominal Wall Varices in Pregnancy.
-
Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
-
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
-
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
-
Imaging diamagnetic susceptibility of collagen in hepatic fibrosis using susceptibility tensor imaging.
-
Imaging in Patients with Cirrhosis: Current Evidence.
-
Imaging in the preoperative evaluation of adult liver-transplant candidates: goals, merits of various procedures, and recommendations.
-
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
-
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
-
Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
-
In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge.
-
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
-
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
-
Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.
-
Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
-
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
-
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
-
Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury.
-
Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration.
-
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
-
Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
-
Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
-
Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis and cryptogenic cirrhosis.
-
Intestinal transplantation: the University of Wisconsin experience.
-
Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC.
-
Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
-
Intrapulmonary shunt confirmed by intracardiac echocardiography in the diagnosis of hepatopulmonary syndrome.
-
Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma.
-
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
-
Is the HCV pipeline heading in the right direction?
-
Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease.
-
JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk.
-
Laparoscopic Hepatectomy for Hepatocellular Carcinoma: The Opportunities, the Challenges, and the Limitations.
-
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
-
Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply.
-
Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection.
-
Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.
-
Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.
-
Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.
-
Liver disease in pregnancy.
-
Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring.
-
Liver renewal: detecting misrepair and optimizing regeneration.
-
Liver transplantation for liver malignancies in Wilson's disease: two novel cases.
-
Liver transplantation for the treatment of hepatocellular carcinoma.
-
Liver transplantation.
-
Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis.
-
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response.
-
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
-
Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.
-
Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy.
-
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
-
MELD-Na Accurately Predicts 6-Month Mortality in Patients With Decompensated Cirrhosis: Potential Trigger for Hospice Referral.
-
Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni.
-
Management of gastrointestinal bleeding in patients with cirrhosis.
-
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
-
Measuring the Toll of Acute Illness-Derived Frailty in Decompensated Cirrhosis.
-
Mechanical pleurodesis aided by peritoneal drainage: procedure for hepatic hydrothorax.
-
Mechanisms of Ascites Development-Reply.
-
Mechanisms of disease progression in NASH: new paradigms.
-
Mechanisms of disease progression in nonalcoholic fatty liver disease.
-
Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
-
MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
-
MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling.
-
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
-
Mirror, Mirror, on the Wall, Who Is the Fittest of Them All? A Novel Prediction Model for Postoperative Hepatic Decompensation in Patients With Cirrhosis.
-
Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis.
-
Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients.
-
Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
-
Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients With Hepatitis C.
-
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis.
-
NASH and cryptogenic cirrhosis: a histological analysis.
-
NASH in HIV.
-
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.
-
Natural Progression of Canine Glycogen Storage Disease Type IIIa.
-
Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes.
-
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.
-
Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy.
-
Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes.
-
Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
-
Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
-
Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
-
Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
-
Nonalcoholic Steatohepatitis.
-
Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
-
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.
-
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.
-
Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease.
-
Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
-
Noninvasive prediction of fibrosis in patients with chronic hepatitis C.
-
Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice.
-
Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis.
-
Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
-
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
-
Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
-
Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.
-
PHOTON-2: hope for patients with HIV and HCV co-infection?
-
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
-
Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.
-
Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis.
-
Pathology and imaging of hepatocellular neoplasms: are findings from Asian populations applicable to non-Asian groups?
-
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
-
Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis.
-
Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
-
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
-
Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.
-
Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
-
Portacaval shunts for ascites: another perspective.
-
Portal hypertensive stomapathy: a newly described entity and its successful treatment by placement of a transjugular intrahepatic portosystemic shunt.
-
Portosystemic shunts in children: a 15-year experience.
-
Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKβ-deficient mouse.
-
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.
-
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
-
Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes.
-
Primary hepatic neoplasms arising in cirrhotic livers can have a variable spectrum of neuroendocrine differentiation.
-
Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit.
-
Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C.
-
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
-
Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates.
-
Proteomic Profiling of Human Hepatic Stellate Cell Line LX2 Responses to Irradiation and TGF-β1.
-
Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
-
Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
-
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
-
Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia.
-
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.
-
Quantifying hepatic shear modulus in vivo using acoustic radiation force.
-
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.
-
Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center.
-
Recent advances in nonalcoholic fatty liver disease metabolomics.
-
Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
-
Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.
-
Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease.
-
Relationship of Liver Stiffness With Congestion in Patients Presenting With Acute Decompensated Heart Failure.
-
Relationship of smoking and fibrosis in patients with chronic hepatitis C.
-
Reply: To PMID 24123276.
-
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
-
Retransplantation of the liver--a seven-year experience.
-
Retrodisplaced gallbladder detected on hepatobiliary scintigraphy.
-
Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
-
Reversible cardiomyopathies--a review.
-
Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.
-
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
-
Risks of a range of alcohol intake on hepatitis C-related fibrosis.
-
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
-
Role of computed tomography in screening for hepatocellular carcinoma in patients with cirrhosis.
-
Role of inflammation in nonalcoholic steatohepatitis.
-
Routine laparoscopy in the management of chronic hepatitis.
-
STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
-
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
-
Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.
-
Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.
-
Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni.
-
Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection.
-
Signals from dying hepatocytes trigger growth of liver progenitors.
-
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
-
Smoothened is a master regulator of adult liver repair.
-
Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases.
-
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
-
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
-
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
-
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
-
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.
-
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
-
Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent.
-
Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis.
-
Splenorenal shunt with underlying cirrhosis of the liver.
-
Standard Versus Extended Duration Direct-Acting Antiviral Therapy in Hepatitis C Patients With Slow Response to Treatment.
-
Staphylococcus aureus pericardial abscess in a patient with liver cirrhosis: case report.
-
Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.
-
Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
-
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.
-
Streptococcus equi primary bacteremia in a hepatitis-C cirrhotic patient.
-
Surveillance for hepatocellular carcinoma.
-
Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.
-
Sympathetic nervous system regulation of liver repair.
-
Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977.
-
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.
-
Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD.
-
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
-
The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.
-
The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis.
-
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.
-
The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients.
-
The clinical management of HCV in the HIV-infected patient.
-
The coagulation cascade in cirrhosis.
-
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
-
The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.
-
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
-
The hedgehog pathway in nonalcoholic fatty liver disease.
-
The hepatopulmonary syndrome: radiologic findings in 10 patients.
-
The impact of cirrhosis on esophageal cancer surgery: An up-to-date meta-analysis.
-
The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
-
The natural history of hepatitis C viral infection.
-
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
-
The pathology of primary biliary cirrhosis.
-
The prevalence and etiology of elevated aminotransferase levels in the United States.
-
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.
-
The rational clinical examination. Does this patient have ascites? How to divine fluid in the abdomen.
-
The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
-
The role of Hedgehog signaling in fibrogenic liver repair.
-
The role of bariatric surgery in the management of nonalcoholic steatohepatitis.
-
Towards a better characterization of cirrhosis-associated cardiomyopathy?
-
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.
-
Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors.
-
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
-
Underlying potential: cellular and molecular determinants of adult liver repair.
-
Understanding the Complexities of Cirrhosis.
-
Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem.
-
Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.
-
Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia.
-
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
-
Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis.
-
Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.
-
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
-
Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis.
-
Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
-
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
-
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.
-
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
-
Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
-
Volume-mediated pulmonary responses in liver transplant candidates.
-
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver.
-
Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic hepatitis C.
-
Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
-
[THE ENZYMES OF THE LEUKOCYTE].
-
Keywords of People
-
Choi, Steven Sok,
Associate Professor of Medicine,
Medicine, Gastroenterology
-
Pang, Herbert,
Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Yancy Jr., William Samuel,
Professor of Medicine,
Medicine, General Internal Medicine